drugset / Trial / NCT05978713
A Study of Tirzepatide (LY3298176) in Healthy Lactating Females
NaSingle-groupOpen-labelBasic science
Summary
The main purpose of this study was to look if the study drug, tirzepatide, gets into the breastmilk and, if yes, how long it takes the body to get rid of it from the breastmilk. The study drug was given as a single injection under the skin in healthy lactating females. For each participant, the total duration of the study was approximately 8 weeks, including screening.
Timeline
- Start
- 2023-07-31
- Primary completion
- 2024-03-12
- Completion
- 2024-03-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tirzepatide | Peptide | 5 mg | Subcutaneous |
Indications
No indication recorded.